This trip might just be worth taking. New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive disorder. That’s noteworthy, since ...
SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
Psychiatric disorders like schizophrenia, bipolar disorder, and depression have a strong genetic signature. Through advanced transcriptome-wide association studies (TWAS), researchers can identify ...
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...
Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...
Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...
A new study suggests that for people treating depression with common medications, the frequency of their yawning might track with how well they are healing. Published in the Journal of Psychiatric ...
Share on Pinterest Emerging evidence suggests that a ketogenic diet could help support mental health. Alexander Spatari/Getty Images A new pilot study reports that young adults experienced a 70% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback